Latest Insider Transactions at Alkermes Plc. (ALKS)
This section provides a real-time view of insider transactions for Alkermes Plc. (ALKS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alkermes plc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alkermes plc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,334
-3.72%
|
$103,354
$31.09 P/Share
|
|
Jun 09
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,333
-3.59%
|
$103,323
$31.95 P/Share
|
|
Jun 08
2025
|
Christopher I Wright Director |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-3.33%
|
$24,583
$31.71 P/Share
|
|
Jun 08
2025
|
Christopher I Wright Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,301
+12.18%
|
-
|
|
May 31
2025
|
Cato T Laurencin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,924
-6.2%
|
$57,720
$30.61 P/Share
|
|
May 31
2025
|
Cato T Laurencin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,013
+20.53%
|
-
|
|
May 31
2025
|
Nancy Lurker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,924
-15.23%
|
$57,720
$30.61 P/Share
|
|
May 31
2025
|
Nancy Lurker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,013
+38.82%
|
-
|
|
May 31
2025
|
Brian P Mckeon Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,924
-5.38%
|
$57,720
$30.61 P/Share
|
|
May 31
2025
|
Brian P Mckeon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,013
+18.29%
|
-
|
|
May 31
2025
|
Nancy Lynn Md Snyderman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,924
-15.21%
|
$57,720
$30.61 P/Share
|
|
May 31
2025
|
Nancy Lynn Md Snyderman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,013
+38.78%
|
-
|
|
May 31
2025
|
Frank Anders Wilson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,924
-5.83%
|
$57,720
$30.61 P/Share
|
|
May 31
2025
|
Frank Anders Wilson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,013
+19.53%
|
-
|
|
May 31
2025
|
Christopher I Wright Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,924
-8.58%
|
$57,720
$30.61 P/Share
|
|
May 31
2025
|
Christopher I Wright Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,013
+26.32%
|
-
|
|
May 31
2025
|
Shane Cooke Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,175
-3.87%
|
$125,250
$30.61 P/Share
|
|
May 31
2025
|
Shane Cooke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,013
+6.91%
|
-
|
|
May 31
2025
|
Richard Gaynor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,924
-5.83%
|
$57,720
$30.61 P/Share
|
|
May 31
2025
|
Richard Gaynor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,013
+19.53%
|
-
|
|
Apr 11
2025
|
Nancy Lurker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,459
-20.18%
|
$39,393
$27.0 P/Share
|
|
Apr 11
2025
|
Nancy Lurker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,075
+45.24%
|
-
|
|
Feb 28
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Open market or private sale
|
Direct |
1,938
-20.07%
|
$65,892
$34.0 P/Share
|
|
Feb 26
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,494
-1.66%
|
$84,796
$34.8 P/Share
|
|
Feb 26
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,617
+3.59%
|
-
|
|
Feb 26
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,049
-1.47%
|
$103,666
$34.8 P/Share
|
|
Feb 26
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,866
+3.21%
|
-
|
|
Feb 26
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,049
-3.77%
|
$103,666
$34.8 P/Share
|
|
Feb 26
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,866
+7.83%
|
-
|
|
Feb 26
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,695
-1.8%
|
$125,630
$34.8 P/Share
|
|
Feb 26
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,322
+3.9%
|
-
|
|
Feb 26
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,402
-2.52%
|
$81,668
$34.8 P/Share
|
|
Feb 26
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,409
+5.37%
|
-
|
|
Feb 26
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
808
-7.72%
|
$27,472
$34.8 P/Share
|
|
Feb 26
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,746
+20.79%
|
-
|
|
Feb 25
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Open market or private sale
|
Direct |
3,743
-32.66%
|
$131,005
$35.26 P/Share
|
|
Feb 23
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-4.41%
|
$119,490
$35.32 P/Share
|
|
Feb 23
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,689
+9.04%
|
-
|
|
Feb 23
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,846
-3.07%
|
$99,610
$35.32 P/Share
|
|
Feb 23
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+6.46%
|
-
|
|
Feb 23
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,587
-1.75%
|
$90,545
$35.32 P/Share
|
|
Feb 23
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,825
+3.8%
|
-
|
|
Feb 23
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
672
-5.54%
|
$23,520
$35.32 P/Share
|
|
Feb 23
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,284
+15.84%
|
-
|
|
Feb 23
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,880
-1.93%
|
$135,800
$35.32 P/Share
|
|
Feb 23
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,738
+4.17%
|
-
|
|
Feb 23
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-1.67%
|
$119,490
$35.32 P/Share
|
|
Feb 23
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,689
+3.63%
|
-
|
|
Feb 22
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,452
-7.26%
|
$190,820
$35.32 P/Share
|
|
Feb 22
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,279
+14.05%
|
-
|